Neuropharmacology of addiction and how it informs treatment
A Lingford-Hughes, B Watson, N Kalk… - British medical …, 2010 - academic.oup.com
Our knowledge about the neuropharmacology of addiction is increasing and is leading to
more informed development of pharmacotherapy. Although the dopaminergic mesolimbic …
more informed development of pharmacotherapy. Although the dopaminergic mesolimbic …
[PDF][PDF] Neuropharmacology of addiction and how it informs treatment
A Lingford-Hughes, B Watson, N Kalk… - British Medical …, 2010 - scholar.archive.org
Many individuals try substances to see what they are like, often during late adolescence or
early adulthood, and for most individuals and for most substances, the use or misuse will be …
early adulthood, and for most individuals and for most substances, the use or misuse will be …
Neuropharmacology of addiction and how it informs treatment.
A Lingford-Hughes, B Watson, N Kalk… - British Medical …, 2010 - europepmc.org
Our knowledge about the neuropharmacology of addiction is increasing and is leading to
more informed development of pharmacotherapy. Although the dopaminergic mesolimbic …
more informed development of pharmacotherapy. Although the dopaminergic mesolimbic …
Neuropharmacology of addiction and how it informs treatment
A Lingford-Hughes, B Watson… - British medical …, 2010 - pubmed.ncbi.nlm.nih.gov
Our knowledge about the neuropharmacology of addiction is increasing and is leading to
more informed development of pharmacotherapy. Although the dopaminergic mesolimbic …
more informed development of pharmacotherapy. Although the dopaminergic mesolimbic …
Neuropharmacology of addiction and how it informs treatment.
A Lingford-Hughes, B Watson, N Kalk… - British Medical …, 2010 - search.ebscohost.com
Our knowledge about the neuropharmacology of addiction is increasing and is leading to
more informed development of pharmacotherapy. Although the dopaminergic mesolimbic …
more informed development of pharmacotherapy. Although the dopaminergic mesolimbic …
[PDF][PDF] Neuropharmacology of addiction and how it informs treatment
A Lingford-Hughes, B Watson, N Kalk… - British Medical …, 2010 - researchgate.net
Many individuals try substances to see what they are like, often during late adolescence or
early adulthood, and for most individuals and for most substances, the use or misuse will be …
early adulthood, and for most individuals and for most substances, the use or misuse will be …
Neuropharmacology of addiction and how it informs treatment
A Lingford-Hughes, B Watson, N Kalk… - British Medical …, 2010 - kclpure.kcl.ac.uk
Our knowledge about the neuropharmacology of addiction is increasing and is leading to
more informed development of pharmacotherapy. Although the dopaminergic mesolimbic …
more informed development of pharmacotherapy. Although the dopaminergic mesolimbic …
[引用][C] Neuropharmacology of addiction and how it informs treatment
A LINGFORD-HUGHES, B WATSON… - British medical …, 2010 - pascal-francis.inist.fr
Neuropharmacology of addiction and how it informs treatment CNRS Inist Pascal-Francis CNRS
Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …
Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …
Neuropharmacology of addiction and how it informs treatment.
A Lingford-Hughes, B Watson, N Kalk… - British Medical …, 2010 - search.ebscohost.com
Our knowledge about the neuropharmacology of addiction is increasing and is leading to
more informed development of pharmacotherapy. Although the dopaminergic mesolimbic …
more informed development of pharmacotherapy. Although the dopaminergic mesolimbic …